Projects funded by the NCN
The role of arginase-1 in antitumor efficacy of cancer immunotherapy using checkpoint inhibitors
2016/23/B/NZ6/03463
Keywords:
tumor immune response immunotherapy arginase checkpoint inhibitors
Descriptors:
- NZ6_1: Adaptive and innate immunity
- NZ5_7: Human disease treatment
- NZ6_3: Animal immunology
Panel:
NZ6 - Human and animal immunology and infection: immunity, immune disorders, immunotherapy, infectious and invasive diseases, microbiology, transplantology, allergology
Host institution :
Uniwersytet Warszawski, Centrum Nowych Technologii Uniwersytetu Warszawskiego
woj. mazowieckie
Principal investigator (from the host institution):
Number of co-investigators in the project: 6
Call: OPUS 12 - announced on 2016-09-15
Amount awarded: 1 767 635 PLN
Project start date (Y-m-d): 2017-07-14
Project end date (Y-m-d): 2021-01-13
Project duration:: 42 months (the same as in the proposal)
Project status: Project settled
Project description
Download the project description in a pdf file
Note - project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.